USP has been awarded a cooperative agreement with the Centers for Medicare and Medicaid Services (CMS) to revise the Part D Prescription Drug Benefit Model Guidelines.
USP has been awarded a cooperative agreement with the Centers for Medicare and Medicaid Services (CMS) to revise the Part D Prescription Drug Benefit Model Guidelines.
The Medicare Prescription Drug, Improvement, and Modernization Act of 2003 (MMA) specifically named USP as the organization charged with developing the list of categories and classes, referred to as the Model Guidelines, that may be used by plans offering the Medicare drug benefit to develop their formularies. Under an earlier cooperative agreement with CMS, USP submitted the Model Guidelines to CMS on December 31, 2004. A majority of the formularies submitted to CMS for approval utilized the USP Model Guidelines.
The Act also directs the Secretary of Health and Human Services to request USP to revise the Model Guidelines "from time to time to reflect changes in therapeutic uses of covered Part D drugs and the additions of new covered Part D drugs."
USP's Model Guidelines Expert Committee was scheduled at press time to convene on November 1 and 2 to begin the revision process. USP leaders said they were looking forward to continuing their activities related to the maintenance of the Model Guidelines.
USP will publish information regarding the process and the work product on its website as it becomes available.
CVS Caremark Makes Changes in Diabetes Coverage for 2025
Published: November 25th 2024 | Updated: November 25th 2024CVS Caremark has removed several diabetes drugs favor of newer products and generics, and is even favoring an insulin infusion system developed by a company that was cofounded by Alan Lotvin, a former executive at CVS Health.
Read More
FDA Clears Phase 2 Trial of Cannabis in PTSD
November 20th 2024After a three-year negotiation, the FDA has dropped its objection to allowing patients to self-titrate dosing of smoked cannabis. But regulators want to see additional information about the device that will be used for inhalation.
Read More